Bright Minds Biosciences (DRUG) Share-based Compensation (IS): 2020-2021

Historic Share-based Compensation (IS) for Bright Minds Biosciences (DRUG) over the last 2 years, with Sep 2021 value amounting to $696,772.

  • Bright Minds Biosciences' Share-based Compensation (IS) was N/A to $299,147 in Q3 2021 from the same period last year, while for Sep 2021 it was $700,787, marking a year-over-year change of. This contributed to the annual value of $696,772 for FY2021, which is 480.63% up from last year.
  • According to the latest figures from FY2021, Bright Minds Biosciences' Share-based Compensation (IS) is $696,772, which was up 480.63% from $120,003 recorded in FY2020.
  • In the past 5 years, Bright Minds Biosciences' Share-based Compensation (IS) registered a high of $696,772 during FY2021, and its lowest value of $120,003 during FY2020.
  • In the last 2 years, Bright Minds Biosciences' Share-based Compensation (IS) had a median value of $408,388 in 2020 and averaged $408,388.
  • Data for Bright Minds Biosciences' Share-based Compensation (IS) shows a peak YoY spiked of 480.63% (in 2021) over the last 5 years.
  • Over the past 2 years, Bright Minds Biosciences' Share-based Compensation (IS) (Yearly) stood at $120,003 in 2020, then spiked by 480.63% to $696,772 in 2021.